APR 08, 2020 12:53 PM PDT

How the Skin Shields Against Zika Infection

WRITTEN BY: Tara Fernandez

Aedes mosquitoes are native of Africa but are commonly found in regions of the Americas, Asia, and the Pacific. These daytime-active bloodsuckers are notorious for being a vector responsible for transmitting a number of diseases: dengue fever, Chikungunya, and Zika fever, to name a few.

To fully understand the molecular dynamics of Zika virus infection, scientists are starting from the beginning — the site of the mosquito bite. A team led by a professor of dermatology at Duke, Amanda MacLeod, used mouse models to map how the skin acts as an antiviral shield during Zika virus transmission in an effort to resist infection. The study was published recently in Science Advances.

The researchers identified that an immune cytokine, interleukin 27 (IL-27), plays an important role in “calling” for backup from other immune cells when the Zika virus penetrates the skin. This innate immune response also stimulates the production of antiviral proteins to neutralize the virus. Fascinatingly, when the virus is introduced into the body through a different point of entry, IL-27 responses are not activated, thereby exacerbating the neurological symptoms of Zika disease.

"What's particularly interesting is that, especially in the absence of acquired immunity and memory responses, our natural innate immune system is highly relevant as it acts much faster—anywhere from hours to a day—than acquired immunity. Most vaccines require boosters over months or years to attain host immunity," says MacLeod.

When the virus evades the immune system, the resulting infection causes a range of symptoms that mostly feature a mild rash, fever, and headache. The consequences of Zika disease are far more devastating when a pregnant woman is bitten by a virus-transmitting mosquito. In these cases, brain deformation and microcephaly (a condition where the infant’s head circumference is much smaller than average) can result.

 

 

The World Health Organization has been calling for a vaccine to be developed quickly to prevent Zika outbreaks, particularly in rural communities. As of 2016, 18 companies were actively chasing the development of a potential vaccine, though experts predict these will take at least a decade to hit the market.

Research findings on the natural protective antiviral pathways, such as those from MacLeod and colleagues, will greatly impact the development of novel preventative and therapeutic strategies against Zika disease.

Speaking on the potential to leverage this data towards thwarting other viral infections, MacLeod commented, "Whether our results could also potentially be applied to other viral pathogens such as SARS Cov-2, the pathogen that causes COVID-19, remains to be tested in future studies.”

 

 

Sources: Medical XPress, Science Advances

 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUN 11, 2021
Cannabis Sciences
Does Cannabis Interact with the COVID Vaccine?
JUN 11, 2021
Does Cannabis Interact with the COVID Vaccine?
As of June 10th 2021, 43% of people in the US aged 12 and over have been fully vaccinated for COVID-19, with 5 ...
JUN 11, 2021
Cell & Molecular Biology
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
JUN 11, 2021
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
The immune system can detect and destroy pathogenic and cancerous cells, but sometimes those dangerous cells can evade t ...
JUN 26, 2021
Cancer
Immunotherapy Drug Shows Promise for Obese Patients with Breast Cancer
JUN 26, 2021
Immunotherapy Drug Shows Promise for Obese Patients with Breast Cancer
Research shows that obese patients with cancers including ovarian and melanoma may respond better to a certain kind of i ...
AUG 20, 2021
Drug Discovery & Development
One Vaccine to Rule Them All: Researchers One Step Closer to Universal Vaccine
AUG 20, 2021
One Vaccine to Rule Them All: Researchers One Step Closer to Universal Vaccine
Researchers have identified two antibodies that can protect animals from diseases caused by alphaviruses, which are RNA ...
SEP 02, 2021
Immunology
Hobit Activates Cancer-Killing Immune Cells
SEP 02, 2021
Hobit Activates Cancer-Killing Immune Cells
Innate lymphoid cells, or ILCs, are specialized immune cells that are increasingly entering the research spotlight. Thes ...
SEP 13, 2021
Microbiology
Flu Season Looms Large as World May Have an 'Immunity Debt'
SEP 13, 2021
Flu Season Looms Large as World May Have an 'Immunity Debt'
Scientists are beginning to speculate about the possibility that the flu season this year will be particularly bad becau ...
Loading Comments...